4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is one of the hot stocks to buy with huge upside potential. On October 13, 4D Molecular Therapeutics announced that the company secured up to $11 million in additional funding and technical support from the Cystic Fibrosis Foundation to accelerate the development of 4D-710, which is a genetic medicine for cystic fibrosis/CF lung disease. The commitment was made following a review of the program and clinical data by the CF Foundation’s independent scientific adv ...